Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Clinical trial NCT04131192 · TERMINATED
Trial details
- NCT number
- NCT04131192
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-11
- Primary completion
- 2021-09-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.